Gain in quality-adjusted life-years in patients with rheumatoid arthritis during 1 year of biological therapy: a prospective study in clinical practice

11 Citationer (Scopus)

Abstract

The quality-adjusted life-year (QALY) is used to measure outcome in rheumatoid arthritis (RA) studies; identification of drivers of a gain in QALY might help predict a treatment response. We investigated how changes in components of the Disease Activity Score-28 joints (DAS28) were associated with the European League Against Rheumatism (EULAR) and European Quality of Life 5 Dimensions (EQ-5D) responses; and what baseline variables predicted the change in QALY following 1 year of biological therapy.
OriginalsprogEngelsk
TidsskriftJournal of Rheumatology
Vol/bind40
Udgave nummer9
Sider (fra-til)1479-86
Antal sider8
ISSN0315-162X
DOI
StatusUdgivet - sep. 2013

Fingeraftryk

Dyk ned i forskningsemnerne om 'Gain in quality-adjusted life-years in patients with rheumatoid arthritis during 1 year of biological therapy: a prospective study in clinical practice'. Sammen danner de et unikt fingeraftryk.

Citationsformater